NCI vs AS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

NCI

26.6
AI Score
VS
AS Wins

AS

46.5
AI Score

Investment Advisor Scores

NCI

27score
Recommendation
AVOID NEW MONEY

AS

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NCI AS Winner
Forward P/E 0 17.6056 Tie
PEG Ratio 1.13 0.5296 AS
Revenue Growth -50.8% 32.1% AS
Earnings Growth 34.0% 500.0% AS
Tradestie Score 26.6/100 46.5/100 AS
Profit Margin 0.2% 7.3% AS
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD AS

Relative Price Performance (Last 90 Days)

NCI 1M: +642.4% · 3M: -58.1% AS 1M: +4.8% · 3M: -8.2%

Current Technical Phase

NCI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 65.4 · Price: $5.12

AS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.9 · Price: $30.19

Fundamentals Snapshot

Metric NCI AS
Market Cap — —
Forward P/E 0.0 25.7
Trailing P/E — 33.4
Revenue (TTM) — —
Revenue Growth -0.5% 0.3%
Gross Margin 0.4% 0.6%
Operating Margin 0.0% 0.1%
EPS -8.26 0.93
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.